Files in this item
A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation
Item metadata
dc.contributor.author | Speir, Mary | |
dc.contributor.author | Tye, Hazel | |
dc.contributor.author | Gottschalk, Timothy A. | |
dc.contributor.author | Simpson, Daniel S. | |
dc.contributor.author | Djajawi, Tirta M. | |
dc.contributor.author | Deo, Pankaj | |
dc.contributor.author | Ambrose, Rebecca L. | |
dc.contributor.author | Conos, Stephanie A. | |
dc.contributor.author | Emery, Jack | |
dc.contributor.author | Abraham, Gilu | |
dc.contributor.author | Pascoe, Ashlyn | |
dc.contributor.author | Hughes, Sebastian A. | |
dc.contributor.author | Weir, Ashley | |
dc.contributor.author | Hawkins, Edwin D. | |
dc.contributor.author | Kong, Isabella | |
dc.contributor.author | Herold, Marco J. | |
dc.contributor.author | Pearson, Jaclyn S. | |
dc.contributor.author | Lalaoui, Najoua | |
dc.contributor.author | Naderer, Thomas | |
dc.contributor.author | Vince, James E. | |
dc.contributor.author | Lawlor, Kate E. | |
dc.date.accessioned | 2025-02-25T10:30:18Z | |
dc.date.available | 2025-02-25T10:30:18Z | |
dc.date.issued | 2023-11-06 | |
dc.identifier | 314923225 | |
dc.identifier | 2f256599-b862-4009-b2b8-10dbb535f34d | |
dc.identifier | 85174261023 | |
dc.identifier | 37846472 | |
dc.identifier.citation | Speir , M , Tye , H , Gottschalk , T A , Simpson , D S , Djajawi , T M , Deo , P , Ambrose , R L , Conos , S A , Emery , J , Abraham , G , Pascoe , A , Hughes , S A , Weir , A , Hawkins , E D , Kong , I , Herold , M J , Pearson , J S , Lalaoui , N , Naderer , T , Vince , J E & Lawlor , K E 2023 , ' A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation ' , EMBO Reports , vol. 24 , no. 11 , e56865 . https://doi.org/10.15252/embr.202356865 | en |
dc.identifier.issn | 1469-221X | |
dc.identifier.other | ORCID: /0000-0002-7358-4479/work/178724821 | |
dc.identifier.uri | https://hdl.handle.net/10023/31484 | |
dc.description | Funding: This work was supported by National Health and Medical Research Council (NHMRC) of Australia project and ideas grants (2011584 to MS; 1140187, 1165591 to EDH; 1143105 to MJH; 1164556, 1183848 to TN; 1101405, 1183070 to JEV; 1145788 to JEV, KEL; 1162765, 1181089 to KEL), fellowships (1144014 to SAC; 1156095 to MJH; 1159230 to JSP; 1141466 to JEV), and Investigator (Leadership 1) grants (2008652 to EDH; 2008692 to JEV) and a Leukaemia & Lymphoma Society Specialised Center of Research Program Grant to MJH (LLS SCOR 7015‐18). TN and KEL are Australian Research Council (ARC) Future Fellows (FT170100313 and FT190100266). DSS was supported by a philanthropic PhD scholarship from the Walter and Eliza Hall Institute of Medical Research. This work was also supported by operational infrastructure grants through the Australian Government IRISS (9000587) and the Victorian State Government Operational Infrastructure Support, Australia. | en |
dc.description.abstract | Programmed cell death pathways play an important role in innate immune responses to infection. Activation of intrinsic apoptosis promotes infected cell clearance; however, comparatively little is known about how this mode of cell death is regulated during infections and whether it can induce inflammation. Here, we identify that the pro‐survival BCL‐2 family member, A1, controls activation of the essential intrinsic apoptotic effectors BAX/BAK in macrophages and monocytes following bacterial lipopolysaccharide (LPS) sensing. We show that, due to its tight transcriptional and post‐translational regulation, A1 acts as a molecular rheostat to regulate BAX/BAK‐dependent apoptosis and the subsequent NLRP3 inflammasome‐dependent and inflammasome‐independent maturation of the inflammatory cytokine IL‐1β. Furthermore, induction of A1 expression in inflammatory monocytes limits cell death modalities and IL‐1β activation triggered by Neisseria gonorrhoeae‐derived outer membrane vesicles (NOMVs). Consequently, A1‐deficient mice exhibit heightened IL‐1β production in response to NOMV injection. These findings reveal that bacteria can induce A1 expression to delay myeloid cell death and inflammatory responses, which has implications for the development of host‐directed antimicrobial therapeutics. | |
dc.format.extent | 19 | |
dc.format.extent | 3952127 | |
dc.language.iso | eng | |
dc.relation.ispartof | EMBO Reports | en |
dc.rights | © 2023 The Authors. Published under the terms of the CC BY 4.0 license. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | en |
dc.subject | BCL-2A1 | en |
dc.subject | Mitochondrial apoptosis | en |
dc.subject | Myeloid cells | en |
dc.subject | NLRP3 | en |
dc.subject | TLR ligation | en |
dc.subject | Biochemistry | en |
dc.subject | Molecular Biology | en |
dc.subject | Genetics | en |
dc.subject | MCC | en |
dc.title | A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews.Infection and Global Health Division | en |
dc.identifier.doi | 10.15252/embr.202356865 | |
dc.description.status | Peer reviewed | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.